New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review.
Click here for original story, ‘Off target’ metabolic effects of anti-inflammatory drugs used for autoimmune disorders needs better treatment strategy
Source: ScienceDaily